CUSIP 482929106COMKLRSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
51 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Samsara Biocapital, LLC | 12.95M | $109.28M | +1.50M | Added |
| 2 | Rtw Investments, LP | 1.30M | $10.97M | +1.30M | New |
| 3 | Paradigm Biocapital Advisors LP | 700.0K | $5.91M | +700.0K | New |
| 4 | Siren, L.L.C. | 435.8K | $3.68M |
| Added |
| 5 | Alyeska Investment Group, L.P. | 403.6K | $3.40M | +403.6K | New |
| 6 | Ikarian Capital, LLC | 360.0K | $3.04M | +360.0K | New |
| 7 | Vanguard Group Inc | 292.8K | $2.47M | +89.7K | Added |
| 8 | Kalehua Capital Management LLC | 139.9K | $1.18M | +139.9K | New Position |
| 9 | Woodline Partners LP | 100.0K | $844.0K | −141.1K | Reduced |
| 10 | Adar1 Capital Management, LLC | 100.0K | $844.0K | +100.0K | New |
See every fund holding Kalaris Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders